Pliant Therapeutics Inc. (PLRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pliant Therapeutics Inc.

    NASDAQ: PLRX · Real-Time Price · USD
    1.52
    0.08 (5.56%)
    At close: Sep 26, 2025, 3:59 PM
    1.47
    -3.29%
    After-hours: Sep 26, 2025, 07:53 PM EDT

    Pliant Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 71.19M 63.23M 33.69M 51.66M
    Short-Term Investments
    		 284.54M 431.01M 297.5M 148.93M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 1.92M 1.87M 394K 838K
    Receivables
    		 2.3M 3M 3.14M 2.47M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 163K 1.27M 1.13M 975K
    Total Current Assets
    		 362.26M 505.5M 340.31M 209.44M
    Property-Plant & Equipment
    		 32.77M 4.78M 9.91M 10.94M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 34.69M 6.65M 10.3M 11.77M
    Total Assets
    		 396.95M 512.15M 350.61M 221.22M
    Account Payables
    		 5.96M 4.53M 1.58M 2.97M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 2.46M 1.87M
    Other Current Liabilities
    		 n/a 9.04M 10.22M 4.91M
    Total Current Liabilities
    		 33.22M 28.52M 23.91M 16.83M
    Long-Term Debt
    		 30.21M 10.05M 9.93M n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 59.65M 10.05M 13.36M 5.33M
    Total Liabilities
    		 92.87M 38.58M 37.27M 22.16M
    Total Debt
    		 60.19M 11.37M 15.81M 7.19M
    Book Value
    		 304.08M 473.58M 313.34M 199.06M
    Book Value Per Share
    		 5.02 8.07 7.46 5.55
    Common Stock
    		 6K 6K 5K 3K
    Retained Earnings
    		 -710.05M -499.75M -338.41M -215.09M
    Comprehensive Income
    		 321K 345K -1.96M -201K
    Shareholders Equity
    		 304.08M 473.58M 313.34M 199.06M
    Total Investments
    		 284.54M 431.01M 297.5M 148.93M

    Add to Watchlist